Spenser Lin No Comments

Healthcare News, Deals, and Investments Update July 27th, 2026

LECO_Weekly-Healthcare-News_7-27-2026Download
  1. Longshore Capital Partners entered a strategic growth partnership with revenue cycle management provider Prochant. Chicago-based Longshore Capital Partners, a lower middle-market private equity firm that takes control positions in North American services businesses with $5 million to $15 million of EBITDA, invested in Prochant, a Charlotte, North Carolina technology-enabled RCM provider serving home medical equipment, DME, infusion and specialty pharmacy operators. Terms were undisclosed. Capital will fund technology, analytics, AI and automation investment, service capacity expansion, new revenue cycle product development and talent acquisition, alongside acquisitions in core markets. Longshore is backing an existing management team under CEO Joey Graham, preserving leadership and culture while accelerating investment in a recurring-revenue outsourced services model. (Link)
  2. SkyKnight Capital, L.P. agreed to acquire a controlling position in Apex Infusion from FFL Partners, which retains a minority stake alongside the clinician-led management team. SkyKnight Capital, a San Francisco private equity firm, signed a definitive agreement to partner with Apex Infusion, a Signal Hill, California omnichannel infusion services provider founded in 2006. FFL Partners, which completed its investment in 2024, remains a minority shareholder, and Apex’s clinician-led management retains significant ownership and continues to lead the business. Apex delivers therapy through a home infusion nursing network and roughly 40 ambulatory infusion suites. SkyKnight intends to fund new market entry, health system and payor partnerships, and technology-enabled access initiatives across a site-of-care shift thesis. (Link)
  3. Winterbird Partners made a growth investment in Minneapolis-based Microsoft services partner Emergent Software. Winterbird Partners invested in Emergent Software, a Minneapolis, Minnesota Microsoft services partner specializing in data modernization, AI deployment, cloud transformation, application development and managed services. Deal value was not disclosed. Led by CEO Jamie Anderson, Emergent manages solutions across the Microsoft ecosystem including Fabric, Azure, Copilot, Foundry and modern data platforms. Proceeds will fund headcount expansion, additional service capabilities and entry into new geographies. For Winterbird, the transaction is a bet on the durability of enterprise AI and data-platform implementation, backing a founder-led services firm against a single hyperscaler ecosystem rather than horizontal consultancy model. (Link)
  4. Healthcare technology platform Focus entered a definitive agreement to acquire Plano, Texas-based managed technology services company GuideIT. Focus, a Chicago-headquartered healthcare technology services company, agreed to acquire GuideIT, a nationally recognized managed technology services provider offering managed IT, cybersecurity, cloud integration, IT and clinical service desk, and medical data services. Terms were undisclosed; GuideIT will operate as GuideIT, A Focus Company. Focus supports more than 100 electronic health record and practice management systems and is consolidating fragmented healthcare vendor relationships into a single accountable partner. GuideIT CEO and board member Russell Freeman described a deliberate partner selection process. The acquisition scales Focus’s Unified Healthcare Platform thesis through capability breadth rather than geographic density. (Link)
  5. Knox Lane completed its $437 million take-private acquisition of Cross Country Healthcare, Inc. (formerly NASD: CCRN), concurrently selling the locums division to portfolio company All Star Healthcare Solutions. Growth-oriented investment firm Knox Lane closed its all-cash acquisition of Cross Country Healthcare at $13.25 per share, valuing the technology-enabled workforce solutions company at roughly $437 million and ending its NASD listing. The deal follows a terminated agreement with Aya Healthcare. Knox Lane simultaneously moved Cross Country’s locum tenens division into All Star Healthcare Solutions, an existing portfolio company, creating immediate platform consolidation. Managing Partner John Bailey and Partner Shamik Patel cited the company’s position at the intersection of workforce services and technology. Joel Tremblay, formerly of Medical Solutions, was installed as CEO, succeeding co-founder Kevin Clark. (Link)
  6. Care Career acquired MAS Medical Staffing, completing its first acquisition phase and lifting consolidated annual revenue beyond $150 million. Woodbridge, New Jersey-based Care Career, a healthcare workforce technology organization led by CEO Siva Konatham, acquired Manchester, New Hampshire-based MAS Medical Staffing, including its travel, allied and per diem operations and technology assets. Financial terms were undisclosed. This is Care Career’s seventh acquisition in 24 months, following IDR Healthcare in February 2026, Source Medical Staffing in October 2025, and four firms in May 2025. The completed first round now exceeds $150 million of annual revenue, with signed LOIs expected to close in Q3 2026 pushing consolidated revenue past a quarter billion by year-end, aided by MAS’s Maestra workforce platform. (Link)
  7. Equality Asset Management-backed Mindoula acquired Valera Health and Janus Healthcare Partners in a double transaction expanding its whole-person care enablement platform. Mindoula, the Silver Spring, Maryland behavioral health company backed by Equality Asset Management, simultaneously acquired New York-based virtual mental health provider Valera Health and Duxbury, Massachusetts psychiatric collaborative care provider Janus Healthcare Partners. Terms were undisclosed. These are Mindoula’s third and fourth acquisitions since its 2013 founding, following Care at Hand and 180 Health Partners. Valera contributes more than 300 multi-state behavioral providers and specialization in suicide risk reduction, DBT and serious mental illness; Valera had itself raised $74.3 million and acquired Vita Health in 2025. Janus adds psychiatry CoCM capability, positioning Mindoula for value-based contracts with payers and health systems. (Link)
  8. Beacon Behavioral Partners entered Ohio and Michigan through a partnership with Ohio- and Michigan-based Pure Psychiatry, adding a 17-location outpatient platform. Plano, Texas-based Beacon Behavioral Partners, a growing network of independent psychiatric practices, acquired Pure Psychiatry, establishing its first presence in Ohio and Michigan and marking one of its largest expansions to date. Financial terms were undisclosed. Pure Psychiatry, led by founders Taylor Hennrick, PA-C, Sarang Patel, PA-C and Dr. Rakesh Amin, provides psychiatric care across all age groups including medication management for anxiety, depression, ADHD and bipolar disorder. Beacon will supply operational, administrative and strategic support to fund de novo clinic openings and provider recruitment. The deal follows Beacon’s appointment of Rob Jardeleza as CEO roughly a week earlier. (Link)
  9. Truehelm-backed Wildflower Health acquired digital pelvic floor platform Every Mother, marking its entry into direct-to-consumer women’s health. Wildflower Health, the San Francisco tech-enabled women’s health company backed by Truehelm, acquired Every Mother, a clinically validated core and pelvic floor therapy platform founded by Allison Rapaport. Terms were undisclosed. Wildflower operates enterprise infrastructure connecting commercial health plans, risk-bearing provider groups and patients across all 50 states, supporting thousands of women’s health providers. Every Mother contributes HSA/FSA-eligible on-demand exercise programs addressing diastasis recti, urinary incontinence, pelvic organ prolapse and pelvic pain. Strategically, the acquisition adds a consumer subscription revenue channel to an enterprise contracting model and extends patient relationships beyond the traditional six-to-twelve-week postpartum drop-off. (Link)
  10. DuneGlass Capital-backed Aviva Aesthetics expanded into Ohio through a partnership with Avon, Ohio-based Vitality Health. Aviva Aesthetics, the Chicago-based entrepreneur-owned medical aesthetics platform launched in 2024 with healthcare services independent sponsor DuneGlass Capital, partnered with Vitality Health, a medical aesthetics and wellness practice in Avon, Ohio founded in 2014 by Alana Mercer, PA-C. Terms were undisclosed. This is Aviva’s eighth partnership of 2026 and its first Ohio location, deepening Midwest presence. Vitality Health provides injectables, laser treatments, skin rejuvenation, weight management and hormone optimization. Aviva’s Entrepreneur Equity structure explicitly positions against traditional private equity roll-ups, allowing founders to retain full equity and control while accessing scale economics and back-office support. (Link)
  11. PE-backed Premier Care Dental Management acquired cosmetic dentistry practice Brookline Smile Artists in Massachusetts. Premier Care Dental Management, the New Hyde Park, New York dental clinical organization operating under the Dental365 brand and backed by The Jordan Company, added Brookline, Massachusetts-based Brookline Smile Artists to its network. Terms were undisclosed. PCDM supports practices across New York, Connecticut, New Jersey, Pennsylvania, Ohio, New Hampshire, Massachusetts and Rhode Island, and has pursued an acquisition-led growth cadence including multiple Ohio additions earlier in 2026. The tuck-in extends the sponsor-backed platform further into higher-margin cosmetic dentistry, a service line with meaningful cash-pay mix, while continuing the roll-up strategy aimed at retiring and scaling-back owner-dentists across the Northeast. (Link)
  12. Shore Capital Partners-backed Innovate 32 partnered with Houston-based Post Oak Dental, expanding its Texas dental support organization footprint. Innovate 32, the Nashville-based dental services organization formed by Chicago lower middle-market private equity firm Shore Capital Partners, closed a partnership with Post Oak Dental, an established Houston, Texas practice. Terms were undisclosed. Under CEO Josh Johnson and a board combining dentists, multi-site healthcare operators and private equity executives, Innovate 32 has assembled a network across Texas, Tennessee, Florida and the Mid-Atlantic since its 2024 founding. Post Oak Dental retains its clinical focus while gaining management infrastructure. For Shore, the affiliation continues a disciplined buy-and-build in general dentistry, prioritizing clinician alignment and local leadership over transactional roll-up. (Link)
  13. Dentalcorp entered the U.S. market with the acquisition of Florida-based Northstar Dental Partners. Toronto-based Dentalcorp, one of the largest dental support organizations in North America, acquired Northstar Dental Partners, a Boca Raton-headquartered group supporting 21 dental practices across South Florida, the Treasure Coast, Southwest Florida and Central Florida. Founder and CEO Dr. Jordan Tomalty retains an ownership stake and will remain instrumental to continued growth. Combined with Dentalcorp’s Canadian network, the partnership brings the total to over 650 supported practices. (Link)
  14. vybe urgent care acquired Liberty Urgent Care’s Horsham and Hatfield centers, supported by growth-oriented debt financing from Live Oak Bank. vybe urgent care, the leading independent urgent care operator in greater Philadelphia, acquired Liberty Urgent Care’s two Montgomery County, Pennsylvania centers, expanding its network from 16 to 18 sites. Terms were undisclosed. The transaction was funded through a recent growth-oriented refinancing completed with Live Oak Bank, which vybe intends to draw on for further acquisitions and de novo development. Liberty founder Erik Soiferman, D.O. joins as Vice President of Occupational Medicine Services, strengthening vybe’s occupational health and workers’ compensation capabilities. The debt-funded structure allows the independent operator to consolidate a fragmented regional market without an equity sponsor. (Link)
  15. Ares Management Corporation (NYSE: ARES) and Rubicon Founders-backed US Heart & Vascular acquired Tennessee physician-owned practice Apex Vascular and its outpatient center. US Heart & Vascular, the Nashville-area cardiovascular support services platform backed by funds managed by the Private Equity Group of Ares Management (NYSE: ARES) alongside Rubicon Founders, acquired Apex Vascular and Apex Vascular Outpatient Center. Terms were undisclosed. Headquartered in Lenoir City, Tennessee, Apex has served East Tennessee for nearly two decades across Knoxville, Crossville, Harrogate, Decatur, Sevierville and Oak Ridge, treating peripheral artery disease, varicose veins, carotid artery disease and dialysis access. Founder Christopher Pollock, MD cited access to resources for regional expansion. The tuck-in deepens USHV’s density in a specialty prized for recurring outpatient procedure volume. (Link)
  16. Paradigm Oral Health bought back BlackRock, Inc.’s (NYSE: BLK) Long Term Private Capital stake in a surgeon-led transaction backed by a Warburg Pincus-led group including Goldman Sachs (NYSE: GS) Alternatives and Sixth Street. Lincoln, Nebraska-based Paradigm Oral Health repurchased BlackRock Long Term Private Capital’s ownership stake, returning majority control to its surgeons and management. The buyback is funded by a significant investment led by Warburg Pincus, a private partnership since 1966, in partnership with Goldman Sachs (NYSE: GS) Alternatives and Sixth Street. Terms were undisclosed. Founded in 2018 by David Rallis, DDS, MD, Paradigm operates an oral surgery and digital dentistry platform built to attract and retain surgeons. The structure is notable for reversing conventional sponsor control: incoming capital supports clinician majority ownership, technology investment, advanced training and de novo clinic expansion. (Link)
  17. Groups Recover Together acquired Better Life Partners in its first-ever acquisition, doubling its New England patient volume.Burlington, Massachusetts-based Groups Recover Together, the value-based opioid use disorder treatment provider backed by Oak HC/FT, Bessemer Venture Partners, Transformation Capital, RRE Ventures, Optum Ventures and Kaiser Permanente Ventures, acquired Better Life Partners in a transaction that closed March 31. Financial terms were undisclosed. Better Life Partners, founded in Vermont in 2018 and backed by aMoon, Alumni Ventures, F-Prime Capital, Maverick Ventures and .406 Ventures, had raised $26.5 million in a 2023 Series B but experienced financial distress. CEO Cooper Zelnick highlighted mental health and virtual primary care capabilities the company intends to scale nationally beyond New England. (Link)
  18. Ohio-based Cardinal Health (NYSE: CAH) agreed to acquire the Diabetes Health business of AdaptHealth Corp. (NASD: AHCO) and, in its entirety, NMS Capital-backed Strive Medical for approximately $360 million in cash. Cardinal Health (NYSE: CAH), headquartered in Dublin, Ohio, deployed roughly $360 million of cash across two definitive agreements to scale its at-Home Solutions platform, subject to working capital adjustments. The AdaptHealth (NASD: AHCO) unit serves over 225,000 patients annually through a centralized mail-order CGM model, while NMS Capital portfolio company Strive Medical adds urology, wound care, ostomy and incontinence supply distribution to 20,000-plus patients. Both transactions build on Cardinal’s Advanced lDiabetes Supply acquisition and are expected to be accretive to non-GAAP EPS within twelve months of close, extending the Ohio distributor’s consolidation of fragmented direct-to-patient supply channels. (Link)
  19. Surgery Partners, Inc. (NASD: SGRY) agreed to sell its ownership interests in Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health for approximately $795 million. Surgery Partners (NASD: SGRY), the Brentwood, Tennessee short-stay surgical facility operator, placed into escrow signature pages to sell its Idaho Falls hospital interests to existing partner Intermountain Health, a Utah-based nonprofit system of 34 hospitals and roughly 400 clinics. The transaction values the combined facilities at approximately $1.15 billion, with total consideration to Surgery Partners of about $795 million before purchase price adjustments. Physician ownership of Mountain View Hospital is unchanged. CEO Eric Evans framed the divestiture as portfolio optimization, refocusing capital toward ambulatory surgery centers. The company reaffirmed 2026 revenue guidance of $3.35–$3.45 billion excluding transaction impact. (Link)
  20. Gentherm Incorporated (NASD: THRM) acquired Ohio-based Innovative Medical Equipment, LLC, maker of the ThermaZone thermal therapy device. Gentherm (NASD: THRM), the Novi, Michigan thermal management and pneumatic comfort technology leader, acquired Innovative Medical Equipment, a Cleveland-area, Ohio provider of the ThermaZone non-opioid hot-and-cold thermal therapy system. Terms were undisclosed. Founder and President Brad Pulver framed Gentherm’s scale and global operating footprint as the growth enabler for the Ohio business. Management expects revenue synergies from cross-selling ThermaZone through Gentherm’s expanded healthcare customer channels. Announced alongside record Q2 2026 revenue of $416 million, raised full-year guidance and a new $400 million repurchase authorization, the deal advances Gentherm’s strategic pivot toward higher-margin medical adjacencies. (Link)
  21. RS2 Healthcare Partners, the Boston-based private equity firm formerly known as Riverside Partners, completed an investment in KMM Group, a Hatboro, Pennsylvania-based vertically integrated precision contract manufacturer serving the medical device industry. RS2 Healthcare Partners, founded in 1989 and rebranded from Riverside Partners in May 2026 to formalize an exclusive lower-middle-market healthcare strategy, closed an investment in KMM Group. Terms and stake size were undisclosed. The firm has raised $1.6 billion in total capital commitments since inception and concentrates on pharma services, medical device contract manufacturing and technology-enabled healthcare, supported by healthcare, clinical and AI advisory boards. KMM produces complex, tight-tolerance components for failure-intolerant end markets. J. Mark King joins as President and CEO, while co-founders John Shegda and Eric Wilhelm move to Chief Technology Officer and Executive Vice President, Business Transformation, preserving customer and employee continuity under sponsor ownership. (Link)
  22. Eurofins Scientific (EUFI.PA) agreed to acquire Element Materials Technology’s Life Sciences Testing Services business in North America for an enterprise value of $400 million. Eurofins Scientific, a global leader in bioanalytical testing, reached agreement with Element Materials Technology to acquire its North America Life Sciences Testing Services business, encompassing biopharma product testing, environmental testing and food testing across a network of 27 laboratories and facilities employing approximately 750 FTEs. The business is expected to generate over $150 million in 2026 revenues with profitability in line with the Eurofins Group average. The transaction expands Eurofins’ geographic footprint in key U.S. and Canadian regions where it has been underrepresented and is expected to close in Q4 2026 subject to customary regulatory approvals. (Link)
  23. Repligen Corporation (NASD: RGEN) agreed to acquire BioLife Solutions, Inc. (NASD: BLFS) for a total enterprise value of approximately $1.5 billion. Repligen will acquire BioLife in a cash-and-stock transaction valued at $31.00 per BioLife share ($11.25 cash plus 0.1442 shares of Repligen common stock), representing a 24% premium to the 90-day VWAP. The deal adds BioLife’s market-leading biopreservation media platform (including CryoStor) and cell-processing tools that support 18 commercially approved therapies and the majority of U.S. commercially sponsored cell-based trials. The transaction is expected to be accretive to growth, margins and adjusted EPS (at least 5 cents in year one and 25 cents in year two) with $20–30 million of synergies; closing is targeted for Q4 2026. (Link)
  24. Nordic Capital agreed to sell life sciences software platform ArisGlobal to Dassault Systèmes (Euronext Paris: DSY) for up to $2 billion, marking a full exit for the Swedish sponsor. Nordic Capital, which manages approximately €39 billion, is exiting ArisGlobal entirely in a sale to Dassault Systèmes (Euronext Paris: DSY) reported at $1.8 billion cash plus a $200 million earnout. Nordic first invested in 2019 via its ninth fund at a reported $700 million enterprise value and added to its stake in 2021. Under Nordic’s ownership the Waltham, Massachusetts company converted to SaaS, completed two bolt-ons and is expected to generate roughly $175 million of 2026 revenue, processing 12 million safety cases annually for 200-plus customers. Closing is expected in the second half of 2026. (Link)
  25. Vireo Growth Inc. (CSE: VREO; OTCQX: VREOF) entered a definitive agreement to acquire certain cannabis cultivation, manufacturing and retail assets of The Cannabist Company Holdings Inc. across five markets for up to $35 million. Vireo Growth, through subsidiary Vireo Health of Arcadia, agreed to acquire selected operations from Cannabist subsidiaries in Colorado, Illinois, Massachusetts, New Jersey and West Virginia for total consideration of up to US$35 million (up to US$18.75 million cash at closing plus up to US$16.25 million in seller notes), subject to adjustments and regulatory approvals. The staged transaction is expected to add up to 25 dispensaries plus cultivation and production assets, deepening Vireo’s Colorado presence and adding four new states. Closing is targeted through 2026 into 2027 amid Cannabist’s CCAA and Chapter 15 proceedings. (Link)
  26. Vireo Growth Inc. (CSE: VREO; OTCQX: VREOF) agreed to acquire Planet 13 Holdings Inc. (CSE: PLTH; OTCQX: PLNH) in an all-share merger. Vireo Growth entered a definitive merger agreement to acquire all outstanding equity of Planet 13, with each Planet 13 share converting into 0.015383618 of a Vireo subordinate voting share (16.6% premium to the 20-day VWAP and 24% premium to the closing price as of July 24, 2026). The transaction deepens Vireo’s Nevada and Florida footprints (adding the flagship Las Vegas superstore, additional dispensaries, cultivation/production capacity and licenses) and adds a Waukegan, Illinois dispensary. On a pro forma basis with prior announced deals, Vireo expects to operate approximately 265 dispensaries across 15 states. Closing is subject to stockholder, regulatory and listing approvals. (Link)
  27. First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) and Westin Acquisition Corp. (NASD: WSTN) announced a definitive business combination agreement to create a publicly traded healthcare and wellness company. The transaction values First Choice at a pro forma enterprise value of approximately $650 million and is expected to accelerate its strategic rebrand to Wellgevity 360, a platform focused on longevity, preventative care and personalized biology-driven solutions. Westin will domesticate and the combined company is expected to trade on NASD. Closing is targeted for Q4 2026 subject to customary approvals and conditions. (Link)
  28. Avanos Medical, Inc. (NYSE: AVNS) stockholders approved the company’s $25.00-per-share take-private by American Industrial Partners, valuing the medtech at roughly $1.272 billion. Avanos Medical (NYSE: AVNS) shareholders voted overwhelmingly in favor of the acquisition by affiliates of funds advised by American Industrial Partners, with approximately 99.75% of shares voted supporting the merger, representing about 74.96% of shares outstanding as of the June 18 record date. Holders receive $25.00 per share in cash, an enterprise value near $1.272 billion and a 72.1% premium to the pre-announcement close, plus an 82.8% premium to the 30-day VWAP. All regulatory approvals had been obtained, with closing expected no later than July 27, 2026. The operationally focused industrials investor takes Avanos private, delisting from the NYSE. (Link)
  29. Royalty Pharma plc (NASD: RPRX) acquired a portion of Neurimmune’s royalty interest in cliramitug for up to $425 million. Royalty Pharma (NASD: RPRX) committed up to $425 million to Zurich-based Neurimmune in exchange for a 3% to 4% royalty on worldwide net sales of cliramitug, an investigational anti-amyloid antibody for ATTR cardiomyopathy. The structure front-loads $125 million upfront, with a further $125 million payable in Q1 2027 and $175 million tied to clinical and regulatory milestones. Cliramitug is licensed globally to Alexion, AstraZeneca Rare Disease, which is running the Phase 3 DepleTTR-CM trial. For Royalty Pharma, the transaction buys exposure to the rapidly growing ATTR-CM market; for Neurimmune, it is non-dilutive capital funding its internal pipeline. (Link)
  30. Aurobindo Pharma Limited (NSE: AUROPHARMA; BSE: 524804), through wholly owned subsidiary Apitoria Pharma Private Limited, agreed to acquire 80% ownership control of A1 Biochem Labs (India) Private Limited and A1 Biochem Labs LLC, USA at a $17 million enterprise value. Aurobindo Pharma (NSE: AUROPHARMA; BSE: 524804) is deploying $13.6 million in cash through Apitoria Pharma for an 80% interest in A1 Biochem Group’s contract research business, struck at a $17 million enterprise value on a debt-free, cash-free basis, subject to closing adjustments. The existing promoter retains 20%, and A1 Biochem Labs (India) will absorb A1 Biochem Labs LLC and the CRO business of A1 Biochem Research (India). The target posted FY26 turnover of ₹1,024.42 million and EBITDA of ₹465.46 million — a 45% margin — across Wilmington and Hyderabad labs with 90-plus scientists. Aurobindo is building an integrated CRDMO platform across the API value chain; closing is expected in 90 to 120 days. (Link)
  31. Scancell Holdings plc (AIM: SCLP) and Neuphoria Therapeutics Inc. (NASD: NEUP) announced an all-share merger agreement and associated financing. Scancell will acquire Neuphoria in an all-share transaction; the combined company will operate as Scancell, list on NASD (in addition to AIM) and advance a pipeline of targeted, off-the-shelf active immunotherapies, led by iSCIB1+ in advanced melanoma. Existing Scancell shareholders are expected to own approximately 85.5% and Neuphoria shareholders 14.5% on a pro forma basis (before financing). Concurrent financing of up to $89 million (equity and debt) is intended to fund the global registrational Phase 3 trial. Closing is targeted for late Q4 2026 subject to shareholder and regulatory approvals. (Link)
  32. Footbridge Partners and ALZA Capital Partners sold Ohio-, Pennsylvania- and Michigan-based medical spa platform The Skin Center to an undisclosed middle-market healthcare private equity fund. Footbridge Partners and ALZA Capital Partners exited The Skin Center, a medical spa and cosmetic surgery platform operating 14 locations across Pennsylvania, Ohio and Michigan, selling to an unnamed middle-market healthcare private equity fund in a recapitalization. Terms were undisclosed. Founded in 1981 by Jerry and Dominic Brandy, the company delivers neurotoxins, dermal fillers, laser skin resurfacing, laser hair removal and cosmetic surgery under CEO Eric Warden. Footbridge co-founder and Managing Partner David Rosner credited management and providers for the outcome. The incoming sponsor inherits a platform positioned for de novo openings and further M&A across the consolidating medical aesthetics market. (Link)

Venture Deals and Other

  1. MannKind Corporation (NASD: MNKD) raised approximately $50 million in a private placement led by Frazier Life Sciences. MannKind (NASD: MNKD) closed a roughly $50 million private placement with institutional investors, led by longstanding biotech investor Frazier Life Sciences. The company sold 10,440,838 common shares at $3.89 and pre-funded warrants for 2,412,632 shares at $3.88, with a $0.01 exercise price and no expiry. Proceeds fund general corporate purposes including a $45 million contingent value rights payment triggered by the FDA’s July 23, 2026 approval of Furoscix ReadyFlow for edema in heart failure and chronic kidney disease patients. (Link)
  2. Insight Partners led a $19 million Series A in AI-native provider credentialing platform Assured, with participation from First Round Capital and Kindred Ventures. Insight Partners led Assured’s $19 million Series A, joined by existing backers First Round Capital and Kindred Ventures, bringing total capital raised to $25 million following a $6 million seed in September 2025. Insight Managing Director Teddie Wardi articulated the thesis directly: incumbent credentialing tools function as systems of record while Assured’s agents perform the work itself, verifying data against more than 2,000 primary sources and cutting credentialing time by 30%. Launched in 2024, the NCQA-certified CVO serves over 100 organizations including Houston Methodist. Proceeds expand R&D and go-to-market teams ahead of a privileging product in early 2027. (Link)
  3. Brevy Care raised $4.77 million with participation from GreyMatter Capital to expand Medicaid reimbursement software for family caregivers. Brevy Care, a developer of software helping family caregivers access Medicaid reimbursements, raised $4.77 million in a round including San Francisco-based GreyMatter Capital, a mental and behavioral health-focused venture firm founded in 2021 that typically writes first checks of $250,000 to $1.2 million. The financing brings Brevy’s total capital raised to $4.92 million. GreyMatter’s thesis centers on early-stage innovation in behavioral healthcare delivery and adjacent care-navigation infrastructure. For investors, Brevy addresses a reimbursement-access gap in self-directed Medicaid programs, a payer-funded and demographically supported category as aging populations shift care burden toward unpaid family members. (Link)
  4. Sixth Street Growth led a $120 million Series D in autonomous revenue cycle management platform Candid Health, with participation from Oak HC/FT, 8VC and Y Combinator. Candid Health raised $120 million led by Sixth Street Growth, the dedicated growth platform of Sixth Street, which manages over $135 billion and has invested more than $13 billion across 90-plus companies. Oak HC/FT, 8VC and Y Combinator participated. The round marks a 3x valuation increase over the February 2025 Series C led by Oak HC/FT. Managing Director Alex Katz cited diligence calls with nearly 40 customers and proof points applying agentic AI at scale. Candid reported 190% year-over-year annual contracted run-rate growth and 180% net dollar retention in 2025, targeting the $280 billion US RCM spend. (Link)
  5. Innovation Endeavors and Xora co-led a $21 million Series A in sensor developer Elio, with participation from Kevin Weil, Scribble VC, UpWest and Resolute Ventures. Elio, a Silicon Valley and Israel-based company building sensors designed for artificial intelligence rather than human vision, raised $21 million co-led by Innovation Endeavors and Xora. Kevin Weil and Scribble VC participated, alongside existing investors UpWest and Resolute Ventures, who led the prior round. Total funding reaches $29 million. Founded by former Meta AR/VR executives, Elio embeds computation directly into optics using dynamic micromirror layers that behave like a neural network, letting AI decide what to capture in real time. Investors are backing applications spanning microscopy, semiconductor inspection, robotics and defense drone detection. (Link)
  6. 7wire Ventures and Allumia Ventures co-led an oversubscribed $16.2 million Series A in Karoo Health, joined by First Trust Capital Partners, SpringRock Ventures and Hyde Park Angels. Karoo Health, an Albuquerque, New Mexico cardiovascular technology company led by CEO Ian Koons, closed a $16.2 million oversubscribed Series A co-led by 7wire Ventures and Allumia Ventures, with First Trust Capital Partners, SpringRock Ventures and Hyde Park Angels participating. Managing Partners Lee Shapiro of 7wire and Jeff Stolte of Allumia join the board. Deployed programs have produced independently analyzed reductions exceeding 40% in emergency department visits and inpatient admissions, plus a greater than 10% total cost of care reduction. Karoo supports 600-plus cardiology providers across 11 states; proceeds fund predictive models and health plan expansion. (Link)
  7. FUSE led a $16 million financing in AI-powered concierge primary care platform Prosper Medical, with participation from Aurum Partners, Better.vc, Cal Innovation Fund, Fluent, Latitude Capital, Knoll Ventures and WTI. Prosper Medical, a San Francisco company founded in 2026 by CEO Ryan McQuaid and CMO James Wantuck, MD, raised $16 million led by FUSE alongside Aurum Partners, Better.vc, Cal Innovation Fund, Fluent, Latitude Capital, Knoll Ventures and Western Technology Investment. Investors are backing repeat founders who previously built PlushCare and sold it to Accolade for $450 million. Unlike cash-pay concierge peers, Prosper is in-network with major insurance plans across all 50 states at a $69 monthly membership, using an AI care layer for longitudinal data aggregation and referral coordination. Proceeds expand the physician network and enter new markets. (Link)
  8. Decathlon Capital Partners provided a non-dilutive growth-debt investment to value-based care technology company Health Endeavors. Decathlon Capital Partners, a growth-debt provider with offices in Palo Alto and Park City, made a strategic investment in Health Endeavors, a Farmington, Utah technology partner to Accountable Care Organizations. Deal size was undisclosed, but the structure requires no dilution of existing shareholders. Managing Director Matt Hoffman framed the investment as conviction in value-based care economics. Health Endeavors serves over 2 million patients with 16-plus years of ACO experience and partnerships with Novant Health and Providence. Decathlon targets companies with $4 million to $100 million revenue, 10%-plus growth and near-term visibility to cash-flow-positive status, avoiding equity dilution and loss of control. (Link)
  9. Vensana Capital and Ohio-based Mutual Capital Partners co-led a $30 million Series A in TYBR Health, with participation from Neovate Capital Partners and existing investors. TYBR Health, a Houston, Texas orthopedic biologics company co-founded and led by CEO Tim Keane, PhD, raised $30 million in Series A financing co-led by Vensana Capital and Mutual Capital Partners, the Cleveland, Ohio venture firm managed by Bill Trainor and Wayne Wallace that invests exclusively in Midwest healthcare IT and medical device companies. Proceeds expand commercial access to the FDA-cleared B3 GEL System, a flowable extracellular matrix hydrogel, broaden indications and fund clinical studies on tissue protection during orthopedic surgery. (Link)

CLICK HERE to sign up
for all news and updates

Spenser Lin No Comments

Healthcare News, Deals, and Investments Update Mar 16th, 2026

LECO_Weekly-Healthcare-News_3-16-2026Download
  1. Aveanna Healthcare Holdings (NASDAQ: AVAH) to acquire Trivest-backed Family First Homecare, expanding pediatric home care footprint and leveraging cash and credit facilities for accretive growth via its financial sponsors Bain Capital and J.H. Whitney Capital Partners Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) agreed to acquire Family First Holding, LLC, a multi-state pediatric home care provider backed by growth investor Trivest Partners since 2021, in a strategic platform expansion deal. The transaction, funded through cash on hand and Aveanna’s existing short-term credit facility, is expected to close in Q2 2026 subject to customary conditions, underscoring lender confidence in the issuer’s credit profile. For Trivest, the exit crystallizes value created since its minority investment, while Aveanna investors gain access to 27 locations across seven states and deeper exposure to high-acuity, home-based pediatric care. Management highlights the acquisition as aligned with Aveanna’s strategy to scale specialized care models and deliver enhanced value to payors and stakeholders. (Link)
  2. Veeva Systems (NYSE: VEEV) pays $100 million for AI brand engagement platform Ostro, enhancing life sciences commercial cloud offering Veeva Systems Inc. (NYSE: VEEV) has acquired Ostro, an AI-powered brand engagement platform, for $100 million to strengthen its commercial suite for life sciences clients. The acquisition integrates AI-driven customer engagement and personalization into Veeva’s CRM and marketing stack. Shareholders gain incremental growth opportunities as pharma and biotech customers increase digital and AI spend. The all-cash deal aligns with Veeva’s strategy of adding focused applications that drive higher wallet share and stickiness across large enterprise accounts. (Link)
  3. Medtronic (NYSE: MDT) to acquire neurovascular device company, Scientia Vascular, for $550 million, bolstering high-growth stroke and neuro interventions pipeline.Medtronic plc (NYSE: MDT) has agreed to acquire a neurovascular device company, Scientia Vascular, for approximately $550 million, targeting expansion in stroke and neuro-interventional therapies. The acquisition enhances Medtronic’s innovation pipeline and positions the company to compete more aggressively in high-growth, procedure-driven markets. Equity investors in Medtronic gain exposure to a differentiated product portfolio that can support long-term revenue growth and margin expansion. The transaction will likely be funded through Medtronic’s balance sheet and is consistent with its strategy of bolt-on acquisitions in key therapy areas. (Link)
  4. RadNet (NASDAQ: RDNT) to acquire AI radiology company Gleamer, advancing imaging AI capabilities and strengthening diagnostic services moat. RadNet, Inc. (NASDAQ: RDNT) has agreed to acquire Gleamer, an AI radiology company, to integrate advanced AI tools into its large-scale imaging network. The acquisition is expected to enhance diagnostic accuracy, workflow efficiency, and throughput across RadNet’s centers. Equity investors view the move as strategic positioning in AI-enabled diagnostics, potentially improving margin structure and differentiation against competitors. The deal also gives Gleamer’s technology a scaled deployment channel, increasing data volume and algorithm performance over time. (Link)
  5. MedImpact Holdings acquires MHW Benefit Partners and MSL Captive Solutions to build integrated risk and pharmacy benefits platform for self-funded employers. MedImpact Holdings, Inc., a leading independent health solutions and pharmacy benefit company, acquired MHW Benefit Partners and MSL Captive Solutions to expand its suite of alternative risk-financing offerings for employer clients. The deal broadens MedImpact’s capabilities into captives and stop-loss insurance, enabling small and mid-sized employers to access structures historically used by large self-insured groups. Investors in MedImpact gain exposure to higher-margin, capital-efficient risk-management services that complement the core PBM and clinical programs. The acquisitions are expected to drive cross-sell opportunities across TPAs, transparent networks, drug savings, and member care solutions, deepening client stickiness and recurring revenue. (Link)
  6. Prospect Medical Holdings sells final Crozer hospital for $1 million, marking distressed exit from Pennsylvania market and transfer to local nonprofit sponsor. Prospect Medical Holdings has completed the divestiture of its final Crozer Health hospital for approximately $1 million, effectively exiting its troubled Pennsylvania hospital portfolio. The low valuation underscores ongoing financial distress and operational challenges in safety-net acute care assets, impacting prior private equity investors in the platform. The facility transitions to a local nonprofit sponsor, shifting governance away from financial sponsors toward mission-driven community operators. Lenders and bondholders will monitor post-transaction capital commitments and turnaround plans as the new owner seeks to stabilize operations and address deferred investment needs. (Link)
  7. CSG.BIO partners with and Asian Egg Bank, adding specialized fertility assets backed by Corbel to its global reproductive health platform. CSG.BIO has entered a partnership with Hanabusa IVF and Asian Egg Bank, acquiring a specialized fertility clinic and donor egg bank focused on Asian patients to expand its reproductive health platform. The deal is supported by capital from Corbel, providing growth funding to scale the mini-IVF and donor egg offerings across new markets. Investors in CSG.BIO gain differentiated assets in a high-growth, cash-pay fertility segment with strong patient demand. The transaction reflects continued private equity and sponsor interest in fertility platforms with unique clinical models and demographic specialization. (Link)
  8. BV Investment Partners takes stake in Moxe Health, backing healthcare data exchange platform in value-based care ecosystem. BV Investment Partners has made an investment in Moxe Health, a healthcare data exchange and interoperability platform focused on payor-provider connectivity. The capital infusion will support product development and commercial expansion as value-based care models require richer, real-time data flows. For BV’s limited partners, the deal offers exposure to a high-growth, recurring revenue SaaS model in healthcare IT infrastructure. Moxe plans to leverage the partnership to accelerate integrations with payors and providers, enhancing network effects and stickiness. (Link)
  9. MedCare Express sold to physician group AMKY Health CT, LLC, transitioning a scaled urgent and primary care practice to new clinical owners. MedCare Express, an integrated urgent and primary care center serving over 30,000 active patients in the Greater Hartford area, has been sold to private physician practice group AMKY Health CT, LLC. Founded in 2007, MedCare Express has built a strong community footprint and recurring patient base, making it an attractive cash-flow asset for physician investors. The buyer plans to support growth while preserving quality standards, signaling a long-term, clinical-operator-led strategy rather than a near-term financial engineering approach. Existing stakeholders benefit from continuity of care and potential service expansion under new ownership. (Link)
  10. Baptist Health to acquire South Arkansas Regional Hospital in El Dorado, extending nonprofit system’s regional footprint and strengthening community care. Baptist Health has signed an agreement to acquire South Arkansas Regional Hospital in El Dorado, Arkansas, adding a key community hospital to its regional nonprofit health system. The acquisition brings the hospital under a larger balance sheet, providing access to capital for facility upgrades and service expansion. For bondholders and donors supporting Baptist Health, the transaction represents a strategic bet on stabilizing rural and small-market acute care. Local stakeholders are expected to benefit from integration into Baptist’s broader clinical network and potential economies of scale in operations and procurement. (Link)
  11. HouseWorks acquires A Caring Experience, scaling private-pay home care footprint and consolidating in the New England market via its financial sponsors InTandem Capital Partners and BPEA Private Equity HouseWorks, a home care provider backed by institutional investors, has acquired A Caring Experience to deepen its presence in the New England home care market. The deal adds local scale, enhances caregiver capacity, and broadens referral relationships in a competitive private-pay and Medicaid-waiver environment. Investors in HouseWorks are positioning for demographic tailwinds and further roll-up opportunities in non-medical home care. The combination is expected to generate operating synergies across scheduling, back-office functions, and recruitment, improving margin profile over time. (Link)
  12. Dynamic Access acquires PICC STAT in Minnesota, expanding vascular access services footprint for clinical and financial sponsors via its financial sponsor RiverGlade Capital Dynamic Access has acquired PICC STAT, a Minnesota-based vascular access provider, in a tuck-in acquisition to grow its specialized PICC and vascular access services network. The deal strengthens Dynamic Access’s regional coverage, allowing payors and health systems to rely on a larger contracted network for on-demand vascular access. Financial sponsors backing outsourced clinical service platforms benefit from increased density, which supports higher route efficiency and utilization. The acquisition underscores ongoing consolidation in niche procedural services where scaled operators can secure better payer contracts and operating leverage. (Link)
  13. Residential Home Health and Hospice acquires Covenant, building scale in home health and hospice across regional markets for sponsor-backed platform. Residential Home Health and Hospice has announced the acquisition of Covenant, adding a substantial home health and hospice footprint to its existing platform. The deal expands the provider’s presence across multiple states, increasing patient census and strengthening referral networks. Sponsor investors behind Residential are pursuing a scale and density strategy in post-acute care, where larger platforms can better manage labor, compliance, and payor relationships. The transaction positions the combined organization to capture more value in value-based and episodic payment arrangements. (Link)
  14. Health Recovery Solutions acquires Rimidi, expanding remote care programs and chronic disease management capabilities for digital health investors. Health Recovery Solutions has acquired Rimidi to broaden its remote patient monitoring and chronic disease management solutions. The combined platform will offer providers and payors an integrated suite for virtual care, data analytics, and patient engagement. Investors see the transaction as consolidation in a crowded remote monitoring space, aiming to reach sustainable scale and differentiated outcomes data. The deal positions the company to participate more fully in value-based arrangements tied to chronic condition control. (Link)
  15. Guideway Care acquires Waypoint Healthcare Solutions, expanding patient navigation and care coordination platform for payor and provider sponsors. Guideway Care has acquired Waypoint Healthcare Solutions to enhance its patient navigation and care coordination capabilities. The transaction deepens Guideway’s relationships with payors and providers seeking to reduce avoidable utilization and improve outcomes. Financial sponsors backing navigation and care-management platforms expect enhanced cross-sell and contract win rates from the expanded offering. The combined entity is positioned to integrate analytics, staffing, and workflow tools under a single, scalable model. (Link)
  16. Centerpoint Health Winchester acquires local medical practice, expanding primary care capacity under community health center sponsorship. Centerpoint Health Winchester has announced the acquisition of a local medical practice, adding providers and patient volume to its community health operations. The deal supports Centerpoint’s mission-driven growth strategy, bringing more primary care access under a single organizational umbrella. For grantors and community-focused investors, the transaction aligns with population health and access objectives rather than pure financial returns. The additional capacity may improve economies of scale in administration and payer contracting for the center. (Link)
  17. ECU Health agrees to sell home health and hospice unit to Liberty, pending state review, rebalancing portfolio toward core acute services ECU Health has agreed to sell its home health and hospice operations to Liberty, subject to state regulatory review. The divestiture allows ECU Health to refocus capital and management attention on its core acute care and hospital assets. Liberty, a home health and hospice operator, gains additional scale and access to new markets, enhancing network density for its investors and lenders. The transaction continues a broader trend of health systems exiting ancillary service lines to specialized operators. (Link)
  18. Sonida Senior Living (NYS:SNDA) completes $1.8 billion strategic merger with CNL Healthcare Properties, deepening senior housing scale and institutional investor backing. Sonida Senior Living has closed a strategic merger with non-traded REIT CNL Healthcare Properties Inc., valuing the combined senior housing platform at approximately $1.8 billion and significantly increasing real estate scale for equity holders. The transaction gives Sonida access to a larger portfolio of senior living communities and a broader institutional capital base anchored by CNL’s healthcare-focused investors. The combined platform is positioned to pursue operational efficiencies, refinancings, and future portfolio optimization to enhance returns. Equity stakeholders in both entities gain from diversification across markets and care levels, while debt providers benefit from greater asset backing. (Link)
  19. Biomemory acquires Catalog Technologies, preparing DNA data storage deployment in data centers in H2 2026 for deep-tech backers. DNA data storage startup Biomemory has acquired Catalog Technologies, consolidating IP and capabilities to commercialize DNA-based data storage solutions. The combined company plans data center deployments in the second half of 2026, targeting hyperscale and enterprise customers seeking ultra-dense, long-term storage. Deep-tech and climate-conscious investors see potential in DNA storage’s low energy footprint compared to traditional media. The acquisition accelerates time-to-market and strengthens Biomemory’s competitive position in a nascent but strategically important storage category. (Link)
  20. Aditxt (NAS: ADTX) buys Ignite Proteomics for $36 million in preferred stock and secures $2.88 million note financing, strengthening precision medicine portfolio. Aditxt has acquired Ignite Proteomics in a stock-based transaction valued at $36 million in preferred equity, alongside securing $2.88 million in note financing. The deal brings proteomics capabilities into Aditxt’s precision medicine and immune monitoring portfolio, offering investors upside in biomarker-driven platforms. The structure, heavily equity-based with incremental debt, reflects a capital-efficient approach for a growth-stage company. Noteholders gain exposure to potential value inflection from integration and commercialization of Ignite’s technologies. (Link)

Venture Deals

  1. Amigo AI Secures $11 Million Series A Led by Madrona to Scale Patient-Facing Clinical AI Agents with significant participation from Optum Ventures Amigo AI has successfully raised $11 million in a Series A funding round led by Madrona, with significant participation from Optum Ventures. This capital infusion brings the company’s total funding to $17 million, following a previous seed round supported by General Catalyst and GSV Ventures. The investment is earmarked for the expansion of Amigo’s “digital residency” platform, which trains AI agents in simulated clinical environments to ensure a 100% safety pass rate before patient interaction. For venture investors, Amigo represents a high-growth opportunity to address the global healthcare workforce shortage by automating complex clinical workflows like triage and care navigation across 100+ languages. (Link)
  2. Arya Secures $21 Million Series A to Scale Relationship OS Platform for Modern Couples Arya has successfully raised $21 million in a Series A funding round led by Canvas Ventures, with participation from existing investors including General Catalyst and SV Angel. This capital injection is aimed at accelerating the development of its “Relationship OS,” a technology platform designed to help couples navigate emotional, financial, and logistical complexities through data-driven insights. For venture investors, the deal represents a strategic entry into the rapidly growing “Family Tech” and wellness space, leveraging AI to provide personalized coaching and conflict-resolution tools. The funding will support product engineering and the expansion of Arya’s user base as it seeks to define a new category of proactive mental health and relationship maintenance. (Link)
  3. Carefam Raises $10.5 Million to Scale AI-Driven Healthcare Recruitment Platform led by Pitango Venture Capital Carefam has successfully raised $10.5 million in a new funding round, bringing its total capital raised to $14 million. The investment is aimed at expanding its specialized conversational AI platform, which automates the end-to-end hiring process for hospitals, long-term care facilities, and home care providers. For venture investors, Carefam addresses the critical global healthcare labor shortage by streamlining credential screening, interview scheduling, and onboarding through vertically integrated AI agents. The funding will allow the company to enhance its technology and scale its operations to help healthcare HR departments reduce administrative friction and accelerate the placement of essential clinical staff. (Link)
  4. Qualified Health Eyes Series A Funding Following $30 Million Seed Round Led by SignalFire, Healthier Capital, and Town Hall Ventures Qualified Health, a pioneer in healthcare orchestration, is reportedly preparing for a Series A funding round to scale its AI-driven platform that streamlines clinical and administrative workflows. This follows a substantial $30 million seed investment led by SignalFire, Healthier Capital, and Town Hall Ventures, which allowed the company to deploy its “operating layer” across major systems like University of Texas and Jefferson Health. For venture investors, the startup represents a high-potential infrastructure play that integrates with EHRs to automate summarization and prior authorization. Potential new investors such as NEA and General Catalyst are being watched as the company targets a nine-figure valuation while navigating rigorous generative-AI safety and regulatory hurdles. (Link)
  5. Translucent Secures $27 Million Series A Led by GV (Google Ventures) to Revolutionize Healthcare Financial Operations Translucent has closed a $27 million Series A funding round led by GV, with participation from existing investors including Benchmark and Unusual Ventures. This capital injection is dedicated to scaling the company’s AI-driven financial orchestration platform, which targets the “existential financial crisis” facing hospitals by automating complex revenue cycle and accounts payable workflows. For venture investors, Translucent represents a critical infrastructure play that addresses thin hospital margins through autonomous financial intelligence. The funding will be used to accelerate product development and expand the company’s footprint across health systems seeking to replace manual, error-prone administrative tasks with real-time, transparent financial data management. (Link)
Spenser Lin No Comments

Healthcare News, Deals, and Investments Update Mar 9th, 2026

LECO_Weekly-Healthcare-News_3.9.2026Download
  1. Race to Contain Iran War Oil Shock as Crude Surges Past 100 Dollars, Markets Slide and Fears Grow Over Prolonged Energy Disruption and Global Inflation Spike G7 finance ministers are preparing an emergency meeting to discuss a possible coordinated release of strategic oil reserves after the Iran war pushed crude above 100 dollars a barrel for the first time since 2022, with Brent briefly nearing 120 dollars. The US‑Israel conflict with Iran has severely disrupted shipments through the Strait of Hormuz, a route that normally carries about a fifth of global oil, driving a sharp spike in crude and gas prices and triggering stock‑market falls. G7 officials fear prolonged fighting could keep energy flows constrained, entrench higher inflation and slow global growth. (Link)
  2. Universal Health Services (NYSE: UHS) to Acquire Talkspace (NASD: TALK) for $5.25/Share in $835 Million All‑Cash Deal to Build National Virtual Behavioral Health Platform Universal Health Services (UHS) has signed a definitive agreement to acquire virtual behavioral health provider Talkspace for $5.25 per share, implying an enterprise value of about $835 million, funded via UHS’s existing revolving credit facility. Talkspace, which generated roughly $229 million in 2025 revenue and delivered more than 1.6 million therapy and psychiatry sessions, brings a network of about 6,000 licensed professionals across all U.S. states, D.C. and Puerto Rico. UHS expects the deal, unanimously approved by both boards and targeted to close in Q3 2026 pending shareholder and regulatory approvals, to be slightly accretive to adjusted EPS in the first year and to accelerate its outpatient and telehealth behavioral health strategy. (Link)
  3. Agilent Technologies (NYSE: A) to Acquire Biocare Medical for $950 Million Cash, Expanding High-Growth Pathology Antibody Platform and Targeting EPS Accretion Within 12 Months Agilent Technologies (NYSE: A) has signed a definitive agreement to acquire Biocare Medical, a high-growth clinical pathology specialist, in an all-cash deal valued at $950 million. Biocare, a leader in IHC, ISH and FISH solutions with more than 300 antibodies and over $90 million of 2025 revenue, has delivered double-digit revenue and profit growth since 2021. The transaction will expand Agilent’s pathology portfolio, strengthen its U.S. footprint and accelerate antibody menu development. Management expects the deal to be accretive to growth, margins and non-instrument mix in year one and to EPS about 12 months post-close. (Link)
  4. Saisystems Health and Serent Capital Partner to Scale AI-Enabled RCM and EHR Solutions Saisystems Health, a provider of technology-enabled revenue cycle management (RCM) and electronic health records (EHR) for post-acute care, has announced a strategic partnership with private equity firm Serent Capital. While the specific financial terms were not disclosed, the investment is aimed at accelerating Saisystems’ product innovation, specifically enhancing its AI capabilities to streamline clinical workflows and financial performance for skilled nursing facilities and physician groups. The partnership leverages Serent’s expertise in scaling healthcare technology companies to expand Saisystems’ market footprint. (Link)
  5. Integration Health Expands Portfolio with Acquisition of Perfusion Life via its financial sponsor 1315 Capital Integration Health has successfully completed the acquisition of Perfusion Life, a leading provider of perfusion staffing and management services. This strategic move is designed to bolster Integration Health’s clinical service offerings across hospitals and surgical centers. By integrating Perfusion Life’s specialized expertise, Integration Health aims to optimize cardiovascular surgical support and staffing efficiency. The acquisition reflects a broader strategy of consolidating niche clinical services to provide a more comprehensive, integrated care delivery model for healthcare systems nationwide. (Link)
  6. Surgery Partners Acquires Preferred Vascular Group to Expand Multispecialty Surgical Platform  its financial sponsor Bain Capital Surgery Partners, Inc. has acquired Preferred Vascular Group (PVG), a provider of vascular care services. This acquisition integrates PVG’s high-quality vascular access centers into Surgery Partners’ extensive national network of ambulatory surgical centers. The deal is intended to enhance Surgery Partners’ specialty care capabilities, particularly in the outpatient vascular space, providing patients with more accessible and cost-effective treatment options. This move follows trends of shifting high-acuity procedures to lower cost, outpatient environments. (Link)
  7. Gedeon Richter Expands Women’s Health Portfolio through Acquisition of Celmatix’s Drug Discovery Assets Global pharmaceutical company Gedeon Richter has acquired the women’s health drug discovery portfolio from Celmatix Inc. The deal includes several preclinical programs focused on first-in-class treatments for conditions such as PCOS and endometriosis. This acquisition strengthens Gedeon Richter’s position as a leader in women’s healthcare by integrating Celmatix’s AI-driven “Transcriptomic Cohort” data to identify novel therapeutic targets. The partnership emphasizes a shared commitment to addressing underserved medical needs in reproductive health through cutting-edge genomic research and clinical development. (Link)
  8. Quantum Health Bolsters Virtual Care Strategy with Acquisition of CirrusMD via its financial sponsors Great Hill Partners and Warburg Pincus. Quantum Health, a leading consumer healthcare navigation company, has acquired CirrusMD, a provider of physician-led integrated virtual care. This acquisition enables Quantum Health to integrate CirrusMD’s “text-first” virtual care platform into its navigation services, offering members immediate access to physicians. The synergy aims to reduce healthcare costs and improve outcomes by closing gaps in care through early intervention. The deal reflects Quantum Health’s strategy to provide a seamless, end-to-end healthcare experience that combines human navigation with advanced digital health tools. (Link)
  9. TPG Capital Partners with Findhelp to Enhance Social Care Access for Underserved Populations Global alternative asset firm TPG, through its Rise Fund, has partnered with Findhelp, the leading social care network in the United States. The investment is geared toward scaling Findhelp’s platform, which connects individuals in need with local social service organizations. TPG’s involvement will support Findhelp in expanding its reach among healthcare providers, insurers, and government agencies. By addressing social determinants of health (SDOH), the partnership aims to improve health outcomes and equity for millions of Americans by streamlining the referral process for food, housing, and financial assistance. (Link)
  10. American Reproductive Centers Acquires Mississippi Fertility Institute for $4.25 Million Alabama-based American Reproductive Centers (ARC) has expanded its regional presence by acquiring the Mississippi Fertility Institute in a deal valued at $4.25 million. This acquisition is part of ARC’s strategic effort to increase access to advanced reproductive technologies and fertility treatments across the Southeast. By integrating the Jackson-based clinic into its network, ARC plans to upgrade facilities and introduce new clinical protocols to improve patient success rates. The deal underscores a growing trend of regional consolidation within the highly specialized fertility and IVF market. (Link)
  11. DoseSpot and Arrive Health Merge to Improve Prescription Access and Price Transparency via its financial sponsors Bain Capital Tech Opportunities, PSG and UPMC Enterprises DoseSpot, a leading e-prescribing platform, and Arrive Health, a provider of real-time prescription benefit tools, have announced a merger. This combination aims to create a unified platform that integrates clinical workflows with financial transparency, allowing clinicians to see accurate drug pricing at the point of care. The merger is designed to improve medication adherence and reduce administrative burdens for providers. By joining forces, the entities seek to solve the critical challenge of drug affordability, ensuring patients can access the most cost-effective medications prescribed by their doctors. (Link)
  12. Adobe Population Health Acquires Eventa LLC to Integrate Respiratory Care Solutions Adobe Population Health has expanded its clinical service suite through the acquisition of Eventa LLC, a specialist in respiratory care management. This acquisition allows Adobe to offer specialized services for patients with chronic respiratory conditions, such as COPD and asthma, within its population health management framework. By incorporating Eventa’s expertise, Adobe aims to reduce hospital readmissions and improve the quality of life for high-risk patient populations. The move highlights Adobe’s commitment to building a comprehensive, multi-disciplinary approach to managing complex chronic diseases. (Link)
  13. Freeman Health System to Acquire Four Arkansas Hospitals from Community Health Systems (CHS) Community Health Systems (CHS) has signed a definitive agreement to sell four of its Arkansas-based hospitals to Freeman Health System. The transaction includes facilities in El Dorado, Springdale, and Bentonville. This divestiture is part of CHS’s ongoing portfolio optimization strategy to focus on core markets. For Freeman Health System, the acquisition represents a significant geographic expansion, allowing the non-profit system to provide a broader continuum of care to residents in the Arkansas region while investing in facility upgrades and clinical services. (Link)
  14. MUSC Health Expands Statewide with $111 Million Acquisition of Palmetto Primary Care MUSC Health has announced a $111 million deal to acquire Palmetto Primary Care Physicians, one of the largest independent multi-specialty groups in South Carolina. This strategic acquisition significantly broadens MUSC’s primary care footprint, adding over 100 providers across 30 locations. The investment is focused on creating a more seamless “hub-and-spoke” model of care, ensuring patients have easier access to MUSC’s specialized academic medical services through their local primary care offices. The deal reflects MUSC’s mission to provide comprehensive, integrated healthcare coverage throughout the state. (Link)
  15. Seal Shield Acquires Vioguard to Expand UV-C Sanitization Solutions in Healthcare Seal Shield, a leader in medical-grade infection control hardware, has acquired Vioguard, a pioneer in UV-C LED disinfection technology. This acquisition enhances Seal Shield’s portfolio of sanitization solutions designed to eliminate pathogens on high-touch surfaces in clinical environments. By integrating Vioguard’s patented UV-C technology, Seal Shield aims to offer more robust, automated disinfection tools to hospitals and clinics, helping to reduce healthcare-associated infections (HAIs). The deal positions Seal Shield as a comprehensive provider of both antimicrobial hardware and advanced disinfection systems. (Link)
  16. National Healthcare Properties and Discovery Senior Living Complete $64 Million Acquisition National Healthcare Properties, in partnership with Discovery Senior Living, has closed a $64 million acquisition of a senior housing portfolio. This investment is part of a broader strategy to modernize and expand senior living communities to meet the rising demand for high-quality assisted living and memory care services. Discovery Senior Living will manage the properties, implementing its “experiential” living model. The deal highlights the continued interest of institutional real estate investors in the senior housing sector, driven by favorable demographic trends and the need for specialized care facilities. (Link)
  17. Patient Advocate Foundation and PAN Foundation Announce Landmark MergerThe Patient Advocate Foundation (PAF) and the Patient Access Network (PAN) Foundation have announced their intention to merge, creating a powerhouse in the patient assistance sector. This merger will combine PAF’s case management and navigation services with PAN’s financial assistance programs for underinsured patients. By joining forces, the organizations aim to provide a more holistic support system for individuals facing life-threatening and chronic illnesses. The unified entity will focus on reducing financial barriers to care and improving health equity through expanded advocacy and direct patient support services. (Link)

Venture and Other News:

  1. Minnesota Medical Technologies Secures $20 Million Series A Led by Versant Ventures Minnesota Medical Technologies (MMT) has closed a $20 million Series A funding round led by Versant Ventures, with participation from existing investors. MMT is a medical device firm focused on developing innovative solutions for urological and GI health. The capital will be used to accelerate the development and clinical validation of its flagship fecal incontinence treatment device. MMT aims to address a significant unmet need in the market with its minimally invasive technology, and the new funding will support toward FDA clearance and commercial launch in the U.S. market. (Link)
  2. llumia Ventures Leads $20.5M Series B in Greater Good Health; DaVita Venture Group and Blue Cross of Idaho’s Granite Financial Join, with $12.5M Debt Facility from HSBC Innovation Banking Greater Good Health, a value-based primary care provider centered on nurse practitioners, raised $20.5 million in Series B funding led by Allumia Ventures, with participation from DaVita Venture Group, Granite Financial Holdings (Blue Cross of Idaho’s investment arm), and existing investors including Optum Ventures and Flare Capital Partners. The company also secured up to $12.5 million in venture debt from HSBC Innovation Banking. Serving over 200,000 patients, Greater Good Health will use the funds to expand its value-based care model, deepen payer partnerships, and extend its geographic footprint, addressing primary care shortages and rising healthcare costs. (Link)
  3. NexCure Raises $19 Million Series A to Advance Immuno-Oncology Pipeline NexCure, a clinical-stage biopharmaceutical company, has successfully raised $19 million in a Series A funding round. While specific lead investors were not named in initial reports, the round included participation from several prominent life science venture firms. The funding will be directed toward advancing NexCure’s lead candidate through Phase 1 clinical trials and supporting the discovery of new drug targets for cancer immunotherapy. NexCure utilizes a proprietary functional screening platform to identify novel proteins that modulate the immune system, aiming to develop therapies for patients who do not respond to existing treatments. (Link)
  4. Sage Secures $65 Million Series C Led by Goldman Sachs including ANEW Capital and Maveron to Scale AI Senior Care Platform Sage, a technology platform designed to modernize eldercare, has raised $65 million in a Series C funding round led by Goldman Sachs Asset Management. The round also saw participation from ANEW Capital and Maveron. Sage’s platform uses AI to help senior living staff monitor residents more effectively, prioritizing care based on real-time data to prevent emergencies. This new capital will be used to scale Sage’s operations, enhance its AI algorithms, and expand its reach into more senior living communities across the United States, addressing the critical staffing shortages in the industry. (Link)
  5. Science Corporation Closes $230 Million Series C to Commercialize BCI Retinal Implant backed by Founders Fund, Lux Capital, and Paradigm Science Corporation, a leader in brain-computer interface (BCI) technology, has raised $230 million in a Series C round. The funding was backed by a diverse group of investors, including Founders Fund, Lux Capital, and Paradigm. The capital is earmarked for the commercialization of its PRIMA retinal implant, a sub-retinal device designed to restore vision in patients with geographic atrophy due to age-related macular degeneration. Following successful clinical results, Science Corp aims to use this massive infusion of capital to build out its manufacturing capabilities and prepare for a global product launch. (Link)
  6. UnityAI Raises $8.5 Million Seed Round to Deploy AI Agents for Healthcare Workforce led by Max Ventures and General Catalyst UnityAI has secured $8.5 million in seed funding led by Max Ventures and General Catalyst. The startup is developing AI-driven “agents” designed to automate administrative tasks and optimize patient flow within hospital settings. The goal of the technology is to alleviate the burnout experienced by healthcare workers by handling scheduling, bed management, and documentation. This initial capital will allow UnityAI to expand its engineering team and launch pilot programs with several large health systems, proving the efficacy of AI in managing complex hospital operations and improving staff retention. (Link)
  7. Grow Therapy Hits $3 Billion Valuation Following New Funding Round Led by TCV with participation from Transformation Capital and SignalFire Mental health platform Grow Therapy has reached a “unicorn” valuation of $3 billion after a new funding round led by TCV, with participation from Transformation Capital and SignalFire. Grow Therapy provides an integrated platform that helps independent therapists manage their practices while connecting patients with affordable, insurance-covered mental health care. The fresh capital will be used to further develop its AI-driven matching tools and expand its network of providers. The high valuation underscores the surging investor interest in mental health startups that solve the accessibility and affordability crisis. (Link)
  8. KeyCare Raises $27.4 Million to Scale AI-Powered Epic-Based Virtual Care featuring 8VC, LRVHealth, and Health Catalyst Capital KeyCare, the nation’s first Epic-based virtual care company, has raised $27.4 million in a funding round featuring 8VC, LRVHealth, and Health Catalyst Capital. KeyCare allows health systems to expand their virtual care capacity by providing access to a network of independent “virtualist” providers who share the same EHR platform. This funding will support the expansion of KeyCare’s AI capabilities, which help triaging patients and streamlining the virtual visit process. By staying within the Epic ecosystem, KeyCare ensures seamless data sharing and continuity of care between virtual visits and in-person health system services. (Link)
  9. Polares Medical Raises $50 Million Series C for U.S. Expansion of Mitral Valve Technology led by Decheng Capital and Endeavour Vision Polares Medical, a clinical-stage medical device company, has closed a $50 million Series C round led by Decheng Capital and Endeavour Vision. The company is developing the MRace Mitral Reshaping System, a hemi-replacement technology for treating mitral regurgitation. The funding will support the company’s expansion of clinical trials in the United States and the pursuit of regulatory approvals. Polares aims to provide a more physiological solution for heart valve repair, and this investment signifies strong investor confidence in the company’s unique approach to structural heart disease. (Link)
  10. Teen-Built AI Calorie App “Cal AI” Generates $40 Million and Gains Interest from MyFitnessPal Cal AI, an AI-powered calorie-tracking app built by a 19-year-old entrepreneur during high school, has reportedly generated $40 million in revenue and attracted significant investment interest, including talks with MyFitnessPal and various Silicon Valley VCs. The app uses advanced computer vision to estimate caloric intake from photos of food with high accuracy. The success of the app highlights the power of “solopreneur” developers in the AI space. While a formal venture round hasn’t been closed, the founder is currently evaluating offers to scale into a broader metabolic health platform. (Link)
  11. Ease Health Emerges from Stealth with $41 Million Led by Andreessen Horowitz (a16z) with support from Benchmark and F-Prime Capital. Ease Health has launched with $41 million in funding led by Andreessen Horowitz (a16z), with support from Benchmark and F-Prime Capital. The company is building what it describes as the “operating system for behavioral health,” a comprehensive software suite that integrates clinical notes, billing, and patient engagement for mental health clinics. By automating the “back-office” burden, Ease Health aims to allow therapists to focus more on patient care. The investment will be used to scale the platform nationally and integrate AI tools that help clinicians track patient progress over time. (Link)
  12. Procode AI Raises $4 Million in Seed Funding to Automate Medical Coding round led by Eniac Ventures and Afore Capital Procode AI, a startup utilizing generative AI to automate medical coding and billing, has raised $4 million in a seed round led by Eniac Ventures and Afore Capital. The company’s platform analyzes clinical documentation in real-time to assign accurate medical codes, reducing errors and speeding up the reimbursement process for providers. This funding will be used to enhance the platform’s accuracy across different medical specialties and to expand the sales team. Procode AI enters a competitive market but aims to differentiate itself through its deep integration with existing EHR systems. (Link)
Spenser Lin No Comments

Healthcare News, Deals, and Investments Update Mar 2nd, 2026

LECO_Weekly-Healthcare-News_3-2-2026Download
  1. IQVIA (NYSE: IQV) Expands Early-Stage Drug Discovery Capabilities with Acquisition of Charles River Discovery Assets IQVIA Holdings Inc. (NYSE: IQV) announced an agreement to acquire select discovery services assets from Charles River Laboratories, strengthening its early-stage R&D capabilities. The assets include five sites offering in vitro drug discovery, AI-driven small molecule platforms, and advanced non-animal research methods backed by over 20 years of scientific data. These capabilities will enhance IQVIA’s integrated platform across drug discovery, from target identification to early safety assessment, covering key therapeutic areas like oncology, neurology, and immunology. The move positions IQVIA to support clients earlier in the drug development lifecycle. The transaction is expected to close in Q2 2026. (Link)
  2. GSK (NYSE: GSK) Agrees to Acquire 35Pharma for $950 Million to Bolster Cardiopulmonary Pipeline GSK announced an agreement to acquire 35Pharma Inc., a Canada-based clinical-stage biopharma company focused on novel protein-based therapeutics. The deal gives GSK full ownership of 35Pharma and its lead asset HS235, a potential best-in-class activin receptor signaling inhibitor targeting pulmonary arterial hypertension (PAH) and pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF). The acquisition strengthens GSK’s Respiratory, Immunology and Inflammation portfolio, addressing unmet needs in a high-burden disease with a growing market projected to reach $18 billion by 2032. GSK will pay $950 million in cash for 100% equity, subject to regulatory approvals, with closing expected thereafter. (Link)
  3. Exa Capital Expands Healthcare Software Portfolio with Acquisition of StaffReady, a Leader in Clinical Workforce Management SaaS Exa Capital, a long-term investor specializing in enterprise software, has acquired StaffReady, a SaaS platform for clinical workforce management in healthcare. Founded in 1995, StaffReady provides cloud-native tools for staff scheduling, compliance, and inspection readiness across hospital departments and life sciences organizations. The deal strengthens Exa Capital’s healthcare technology portfolio and marks its entry into clinical workforce optimization, a sector critical to operational efficiency and patient safety. StaffReady will continue to operate independently under Exa’s decentralized model, with its leadership team remaining in place to drive innovation and sustainable growth backed by Exa’s strategic support. (Link)
  4. Numantec Expands Infusion Therapy Portfolio with Acquisition of DualCap® Product Line from Merit Medical financed by Banco BPM and Muzinich & Co Numantec, a global infusion therapy device manufacturer, has acquired the DualCap® product line from Merit Medical Systems through its U.S. subsidiary, Health Line International Corp. The DualCap® is an established antimicrobial cap used in vascular access and infusion therapy, enhancing infection prevention and clinical efficiency. The acquisition strengthens Numantec’s vascular access portfolio and creates growth opportunities across Europe and the U.S., where DualCap® already has a strong customer base. Health Line, which has manufactured DualCap® since before 2017, will ensure continuity of supply. The transaction was financed by Banco BPM and Muzinich & Co. (Link)
  5. Healthcare Triangle (Nasd: HCTI) Announces $3.96 Million Registered Direct Offering Priced at-the-Market to Support Growth Initiatives Healthcare Triangle, Inc. (Nasdaq: HCTI), a digital transformation leader for healthcare and life sciences, announced it has entered into definitive agreements to sell 681,553 shares of common stock (or prefunded warrants) at $5.81 per share in a registered direct offering priced at-the-market under Nasdaq rules. The gross proceeds are expected to total approximately $3.96 million before fees and expenses. The offering, conducted under the company’s effective Form S-3 shelf registration, is expected to close around February 27, 2026, subject to customary conditions. (Link)
  6. The HWP Group Acquires Global Market Access Solutions to Strengthen Market Access and Health Economics Expertise Backed by NMS Capital The HWP Group, a leading medical communications and strategic consulting firm for the life sciences sector, has acquired Global Market Access Solutions (GMAS), a global consultancy specializing in market access and health economics. The acquisition expands HWP’s capabilities in HEOR, pricing and payer insights, evidence synthesis, and lifecycle value strategy, enhancing support across the entire product lifecycle—from early development to sustained patient access. CEO Jani Hegarty said the deal reinforces HWP’s mission to bridge science and real-world access. Backed by NMS Capital, the move positions HWP as a fully integrated partner for pharmaceutical and biotechnology innovators. (Link)
  7. QC Capital Invests in My Pediatric Doctor to Expand Nationwide 24/7 Urgent Pediatric Telehealth Platform QC Capital Group, a Charlotte-based alternative investment firm, announced a strategic investment in My Pediatric Doctor, a nationwide 24/7 pediatric telehealth platform offering on-demand access to board-certified providers. Led by CEO Eric Doherty, the company aims to modernize pediatric care by reducing emergency room visits and improving accessibility for families across all 50 states, Guam, and Puerto Rico. The platform integrates with healthcare systems to relieve pressure on hospitals while maintaining high clinical standards. QC Capital CEO Chris Salerno called the partnership a key step in delivering trusted, affordable pediatric care nationwide. (Link)
  8. HCAP Partners Leads Follow-On Acquisition to Expand Integrated Diagnostic Services Platform with Core Analytics Lab & Radiology other partners include California Bank & Trust, along with co-investment from St. Cloud Capital and Southfield Mezzanine San Diego-based private equity and impact investor HCAP Partners has completed a follow-on acquisition for its Integrated Diagnostic Services (IDS) platform with the addition of Santa Fe Springs-based Core Analytics Lab & Radiology. The deal expands IDS’s footprint into Northern California and adds mobile laboratory diagnostics to its service offerings. Financing was provided by HCAP Partners, California Bank & Trust, along with co-investment from St. Cloud Capital and Southfield Mezzanine. Post-acquisition, IDS will serve over 440 facilities, offering bundled radiology and lab services to skilled nursing, long-term care, and home health providers across California. (Link)
  9. Gemspring Capital Expands Spinal Device Platform as Portfolio Company Zavation Medical Acquires ChoiceSpine Zavation Medical Products, a Gemspring Capital portfolio company and manufacturer of spinal implants and biologics, has acquired ChoiceSpine Holdings, a Knoxville-based spinal implant designer. The transaction broadens Zavation’s product portfolio and national reach, leveraging its vertically integrated manufacturing to accelerate innovation. ChoiceSpine will keep its brand and operations during integration. Concurrently, Zavation appointed Derek Kuyper as CEO of the combined entity. Gemspring Capital said the acquisition strengthens Zavation’s market position and supports its strategy to build a scaled, innovation-driven spinal platform. (Link)
  10. Fulcrum Equity Partners Leads $10M Growth Round in MedScout to Advance AI-Driven MedTech Sales Execution with participation from Live Oak Venture Partners and Stage 2 Capital Austin-based MedScout has raised $10 million in a growth funding round led by Fulcrum Equity Partners, with participation from Live Oak Venture Partners and Stage 2 Capital. The funding more than doubles MedScout’s valuation since its Series A in July 2024. The company also launched “Strategies,” a suite of AI agents designed to help MedTech commercial teams translate strategy into field-level execution. MedScout plans to use the capital to expand its AI capabilities amid surging enterprise demand. The company reported tripled enterprise revenue and rapid adoption growth as investors back its data-driven approach to commercial alignment in MedTech sales. (Link)
  11. Chapters Health Expands West Coast Footprint with Housecall Providers Deal, Strengthening Nonprofit Hospice Network and Growth Potential Chapters Health System, the nation’s largest nonprofit hospice network, has signed a definitive agreement to acquire Housecall Providers from CareOregon, pending approval by the Oregon Health Authority. The move expands its Pacific Northwest presence and adds to its 2025 West Division growth, which includes affiliates in California, Nevada, and Oregon. The integration aligns two nonprofit leaders in community-based chronic and homecare, reinforcing Chapters’ national scale, operational synergies, and value-based care capabilities—key drivers for investors tracking nonprofit healthcare consolidation and sustainable care delivery models. (Link)
  12. Dovida Enters U.S. Market with Acquisition of A Place At Home, Expanding Global Home Care Footprint to Seven Countries Global home care provider Dovida has entered the U.S. market through the acquisition of A Place At Home, a nationwide home care franchise network. The move marks Dovida’s seventh international market and first presence in North America, extending its person-centered care model across the United States. A Place At Home’s leadership will remain in place to ensure continuity for franchise owners and caregivers. The deal aligns with Dovida’s strategy to expand amid increasing demand for high-quality in-home care for older adults, reinforcing its mission to deliver personal, dignified, and relationship-based care on a global scale. (Link)
  13. Ally Bridge Group Backs Creation of Precision IO Group as Quantum Surgical Acquires NeuWave Medical to Advance Robotic Cancer Care Quantum Surgical has acquired NeuWave Medical, Inc., combining expertise in robotic and microwave ablation technologies under a new parent entity, Precision IO Group Inc., led by medtech veteran Kurt Azarbarzin. Supported by investment from Ally Bridge Group, the group aims to expand access to minimally invasive, AI-driven, and remote cancer treatments worldwide. Both companies will continue operating independently, ensuring ongoing product availability. The Epione robotic platform and NeuWave’s microwave system will together drive broader adoption of next-generation interventional oncology procedures across global healthcare markets. (Link)
  14. HIAAH Expands Mental Health Footprint with Strategic Acquisition of Broward Center for Counseling to Strengthen Market Presence in Broward County HIAAH, a U.S.-based integrated health care and mental health services provider, has acquired the Broward Center for Counseling as part of its expansion strategy in Broward County. The move reinforces HIAAH’s mission to broaden access to high-quality, compassionate mental health care while improving operational efficiency and client experience. The newly branded Broward Center for Counseling by HIAAH will continue providing individualized therapy for anxiety, depression, trauma, and relationship issues, now supported by enhanced infrastructure and a holistic, multidisciplinary care model. The acquisition aligns with HIAAH’s growth objectives and positions it for stronger long-term value creation in the behavioral health sector. (Link)
  15. UConn Health Finalizes Waterbury Hospital Acquisition from Prospect Medical Holdings UConn Health is set to complete its acquisition of Waterbury Hospital from bankrupt for-profit Prospect Medical Holdings at midnight on Saturday, marking a major expansion of its health network. The facility will operate under a new entity, UConn Health Community Network, beginning Sunday at 12:01 a.m. Immediate changes include new signage, updated processes, and a ribbon-cutting ceremony on March 4. UConn Health plans to assess Waterbury’s healthcare needs, modernize information and safety systems, and introduce new specialists and services from its flagship John Dempsey Hospital in Farmington to strengthen local medical care and patient outcomes. (Link)
  16. Bradford Health Expands into Midwest with Acquisition of Parkdale Center, Strengthening National Footprint in Specialized Professional Addiction Care Bradford Health Services, a nationally recognized addiction treatment provider, has acquired Parkdale Center, a leading Indiana-based facility specializing in confidential addiction recovery programs for healthcare providers, attorneys, executives, and other licensed professionals. The deal extends Bradford’s geographic reach into the Midwest and enhances its portfolio of evidence-based treatment offerings. Parkdale’s expertise in professional recovery, career reentry, and collaboration with licensing boards complements Bradford’s mission of clinical excellence and sustainable outcomes. Both organizations will maintain their brands while integrating operations to deliver expanded, high-quality care for professionals nationwide. Terms of the transaction were not disclosed. (Link)
  17. Zemantics Ventures Strengthens Healthcare Portfolio with Acquisition of Consilium360 and MedWell360 Zemantics Ventures, a strategic investment and operating platform, has acquired Consilium360 and MedWell360 to expand its presence in healthcare services and workforce solutions. The move enhances Zemantics’ capabilities in enterprise HR optimization, patient access, and technology-enabled operational performance. Consilium360 provides data-driven workforce and HR strategy solutions for healthcare systems, while MedWell360 specializes in scheduling and access center services. The acquisitions support Zemantics’ strategy of scaling founder-led, service-driven businesses through strategic capital, shared infrastructure, and technology. John Brown, Founder and Healthcare HR Executive, will continue in a leadership role to ensure continuity and growth. (Link)
  18. Epiphany Dermatology Expands Kansas Presence Through Partnership with Resolute Dermatology Epiphany Dermatology, a leading national dermatology network, has expanded its presence in Kansas by partnering with Resolute Dermatology, LLC, founded in 2020 by Dr. Daniel Christiansen. Based in Leawood and Shawnee, KS, Resolute Dermatology is recognized for high-quality patient care in the greater Kansas City area. The partnership brings Dr. Christiansen and his team—Drs. Julie Green, Elizabeth Spenceri, and PAs Judy Ky and Kylie Witham—into Epiphany’s growing network. Through this collaboration, Resolute gains operational and clinical support while sharing expertise across Epiphany’s 123 locations in 18 states, strengthening access to exceptional dermatologic care in the region. (Link)

Venture and Other News:

  1. NewSpring Healthcare Leads $140 Million Investment in Honest Health to Accelerate Value-Based Care Expansion included participation from K2 HealthVentures and existing investors Rubicon Founders, Oak HC/FT, WCAS, and Durable Capital Partners Honest Health, a physician-led value-based care enablement firm, raised $140 million in a funding round led by NewSpring Healthcare, the healthcare-focused arm of NewSpring Capital. The round included participation from K2 HealthVentures and existing investors Rubicon Founders, Oak HC/FT, WCAS, and Durable Capital Partners. Proceeds will support national expansion and partnerships with health systems and payers. NewSpring will leverage its sector expertise to guide Honest Health’s growth in risk-based care models. (Link)
  2. NantWorks Leads $240 Million Investment in SHINE Technologies; Dr. Patrick Soon-Shiong Joins Board to Advance Fusion and Cancer Therapies SHINE Technologies, a leader in fusion-based technology, has raised $240 million in new equity funding led by NantWorks, founded by Dr. Patrick Soon-Shiong, who also joins SHINE’s Board of Directors. Other investors include Fidelity, Sumitomo, Pelican Energy, Deerfield, and Oaktree. The funding supports SHINE’s commercial fusion initiatives in neutron testing, medical isotope production, and nuclear waste recycling, while accelerating Lu-177 radioisotope supply for precision cancer therapies. The strategic partnership gives NantWorks priority access to Lu-177, aligning SHINE’s fusion expertise with Soon-Shiong’s mission to transform oncology. With this round, SHINE’s total funding surpasses $1 billion. (Link)
  3. BrainCheck Secures Additional $13 Million Series A to Scale AI-Enabled Cognitive Care Platform and Embedded Assessment Workflows Across Value-Based Health Systems BrainCheck, a digital platform for cognitive assessment and care, has raised an additional $13 million in Series A financing led by Next Coast Ventures, with S3 Ventures and UPMC Enterprises participating. The capital will expand its enterprise cognitive care infrastructure, including deeper EHR integration, longitudinal monitoring, AI-assisted population health analytics, and deployment across primary care and specialty settings. BrainCheck is partnering with collaborative care organizations to operationalize scalable cognitive care pathways in time-constrained, value-based environments. Used by 500+ providers, its FDA Class II BrainCheck Assess™ has powered over 640,000 assessments and 14,000 care plans to date. (Link)
  4. YOU(th) Health Tech Raises $4.5M to Expand Smartphone-Based Preventive Health Screening Globally round led by Callisto Health, with support from caesar., adesso Ventures, Antler, Moonstone, and 1024 Ventures. Digital health startup YOU(th) has raised $4.5 million in a funding round led by Callisto Health, with support from caesar., adesso Ventures, Antler, Moonstone, and 1024 Ventures. Angel investors include Jean-Charles Samuelian (Alan, Mistral AI) and Patrick Andrae (HomeToGo). The company aims to democratize preventive healthcare by turning everyday smartphone data—such as facial videos, voice, typing patterns, and step counts—into quick health assessments detecting over 50 biomarkers across 10 organ systems. The funds will support product development and expansion of engineering, data science, and medical research teams to make preventive care accessible worldwide. (Link)
  5. General Catalyst Leads $6.5M Seed in Baba to Build Continuous AI‑Enabled Patient Advocacy for Aging Americans General Catalyst has led a more than $6.5 million seed round in Baba, a patient advocacy startup founded by Connor Sweeney to help seniors and families navigate complex healthcare logistics. Inspired by his grandparents’ experience after his grandmother’s stroke, Sweeney built Baba to pair older adults with dedicated human advocates, augmented by AI tools for daily check-ins, medication management, and insurance and benefits navigation. With advocacy reimbursed by Medicare for over 70 million beneficiaries, Baba aims to scale continuous, preventive support through partnerships with home health, nursing homes, and post-acute care providers. (Link)
  6. Coral Care Raises $13M Series A Led by Haymaker Ventures, Joined by FCA Ventures, Peterson Ventures, Alleycorp, Reach Capital, Jefferson River Capital, Greymatter Capital, Mother Ventures, and Charge Ventures to Expand In-Home Pediatric Therapy Nationwide Coral Care, a platform providing in-home pediatric speech, occupational, and physical therapy, has raised a $13 million Series A round led by Haymaker Ventures, with participation from FCA Ventures, Peterson Ventures, Alleycorp, Reach Capital, Jefferson River Capital, Greymatter Capital, Mother Ventures, and Charge Ventures. The funding will fuel national expansion in Dallas, Houston, Chicago, Philadelphia, and Pittsburgh, bringing operations to five states. Founded in 2023 by Jen Wirt, Coral Care supports over 400 licensed clinicians through its technology platform that streamlines administrative tasks and enables accessible, insurance-covered, in-home therapy for children across the U.S. (Link)
  7. AI Healthtech Startup Lexi Raises $1.4M Pre-Seed Round Led by Informed Ventures, Backed by HBS Alumni Angels, Stanford Angels, Alumni Ventures, and Van Wickle Ventures Lexi, an AI-native communication platform for healthcare, has raised an oversubscribed $1.4 million pre-seed round led by Informed Ventures, with participation from HBS Alumni Angels, Stanford Angels, Alumni Ventures, and Van Wickle Ventures. Founded by Linh Pham and Siddharth UR, Lexi tackles language barriers affecting 30 million U.S. patients by providing secure, instant AI interpretation within clinical workflows. A successful pilot with Lowell Community Health Center delivered over 60,000 minutes of interpretation, reduced costs by 60%, and improved privacy and efficiency. Lexi plans to expand deployments across health centers while broadening language coverage and patient partnerships. (Link)
Spenser Lin No Comments

Healthcare News, Deals, and Investments Update Feb 23rd, 2026

LECO_Weekly-Healthcare-News_2.23.2026Download
  1. Trump’s Section 122 Tariffs Hit UK, EU Hardest as Supreme Court Strikes Down IEEPA Levies, Benefiting Brazil, China, India The U.S. Supreme Court ruled 6-3 that President Trump wrongly used IEEPA for tariffs, prompting a shift to 15% global duties under Section 122 of the 1974 Trade Act. Trade-weighted averages rise for UK (+2.1 points), EU (+0.8), Japan (+0.4), South Korea (+0.6), while plunging for Brazil (-13.6), China (-7.1), and India. Experts note heaviest IEEPA-hit nations gain most relief; early deal-makers suffer hikes. EU seeks clarity on prior 15% cap deal. China assesses; India delays trade talks. (Link)
  2. Blue Owl Capital Shares Slide Again as Debt Fund Liquidity Changes and $1.4B Asset Sale Heighten Private Credit Concerns Blue Owl Capital’s stock extended its recent selloff as investors reacted to the firm’s strategy to return capital from one of its private debt funds following a $1.4 billion loan portfolio sale. The alternative asset manager adjusted redemption mechanics for Blue Owl Capital Corp II, opting to return capital through asset sales rather than traditional quarterly liquidity windows. The developments have fueled broader concerns around liquidity, valuation transparency, and structural risks within retail-oriented private credit vehicles. The market reaction underscores growing scrutiny of private credit managers as fundraising slows and pressures rise. (Link)
  3. Cristiano Ronaldo Invests $7.5 Million in Herbalife’s (NYSE: HLF) Pro2col AI Wellness Tech, Secures 10% Stake in Key Subsidiary Herbalife Ltd. (NYSE: HLF) announced soccer superstar Cristiano Ronaldo’s $7.5 million investment in HBL Pro2col Software, LLC, gaining a 10% equity stake. The deal includes service and sponsorship commitments, highlighting Ronaldo’s faith in Pro2col’s AI-driven, personalized wellness platform. Since partnering with Herbalife in 2013, Ronaldo endorsed products like Herbalife24 CR7 Drive. Pro2col uses data for custom plans, tracks habits via Pro2Score, and aids distributors. Now in U.S., Canada, and Puerto Rico beta and expanding to EMEA, boosting their data-centric strategy. (Link)
  4. True North PE Injects INR 150Cr ($16.5M) into High-Growth ACN Healthcare RCM; $20M More Eyed as India’s Outsourcing Boom Accelerates True North Private Equity’s Credit Opportunities Fund I invests Rs 150 crore in ACN Healthcare RCM, a top Revenue Cycle Management provider with India operations and US clients. ACN boasts 68% CAGR growth over three years, employing 3,000+ professionals across four centers. Funds will fuel service expansion, strategic moves, and new facilities. More PE funds eye up to $20M in the round. India’s RCM market surges at 15-17% CAGR, driven by outsourcing, AI, and global demand, with India holding 50% of worldwide talent amid healthcare complexities. (Link)
  5. Danaher (NYSE: DHR) to Acquire Masimo (NASDAQ: MASI) in $9.9 Billion Cash Deal at $180/Share, Boosting Diagnostics with Pulse Oximetry Leader Amid Expected Synergies Danaher Corporation (NYSE: DHR) has agreed to acquire Masimo Corporation (NASDAQ: MASI) for $180 per share in cash, valuing the deal at $9.9 billion enterprise value. The acquisition bolsters DHR’s Diagnostics segment with MASI’s pulse oximetry and patient monitoring tech, expecting high-single-digit revenue growth, $530M+ 2027 EBITDA, $125M cost synergies, and $50M revenue synergies by year five. Deal closes H2 2026 pending approvals; accretive to EPS by $0.15-$0.20 year one, $0.70 by year five. (Link)
  6. Johnson & Johnson (NYSE:JNJ) Explores $20 Billion Sale of DePuy Synthes Orthopedics Unit Amid Spinoff Plans Johnson & Johnson (JNJ.N) is preparing to sell its orthopedics unit, DePuy Synthes, in a deal potentially exceeding $20 billion, targeting private equity firms as top buyers, Reuters reports. The unit, which generated $9.3 billion in 2025 sales from hip, knee, and shoulder implants, was slated for a standalone spinoff within 18-24 months to focus on high-growth segments. J&J is assembling financials for upcoming buyer meetings; large PE firms may team up, with interest from medical device rivals possible. This follows resolutions of most ASR hip lawsuits. CFO eyes tax-free spinoff but open to sales. (Link)
  7. PE-backed Elevate Patient Financial Solutions acquires Centauri Health Solutions’ health systems services unit, expanding Medicaid eligibility, enrolment and complex revenue cycle capabilities across U.S. hospital clients Private equity–backed Elevate Patient Financial Solutions has agreed to acquire Centauri Health Solutions’ Health Systems Services (HSS) unit, a Phoenix-based provider of specialized eligibility and enrollment services for Medicaid and disability programs, out-of-state Medicaid billing, and complex revenue cycle solutions for hospitals and health systems. The deal strengthens Elevate PFS’s position in patient financial engagement and government program eligibility, broadens its national footprint, and is expected to drive cross-selling opportunities across existing provider relationships while supporting uncompensated-care and Medicaid-reliant populations. (Link)
  8. TriSalus Life Sciences (Nasdaq: TLSI) Prices $40M Common Stock Offering at $4.10/Share with 15% Over-Allotment Option, Closing February 23, 2026 TriSalus Life Sciences, Inc. (Nasdaq: TLSI) priced its underwritten public offering of 9,756,100 common shares at $4.10 each, expecting $40 million in gross proceeds before expenses. The oncology-focused medtech firm granted underwriter Lake Street Capital Markets a 30-day option for 1,463,415 additional shares (15% of the offering). Closing is set for February 23, 2026, subject to conditions, via an effective S-3 shelf registration. Funds will support general corporate purposes, amid devices like TriNav for tumor drug delivery and nelitolimod immunotherapy research. (Link)
  9. CenterWell, the healthcare services division of Humana Inc. (NYS: HUM) Expands Florida Footprint with Acquisition of MaxHealth from Arsenal Capital Partners CenterWell, the healthcare services division of Humana Inc., has completed its acquisition of MaxHealth from private equity firm Arsenal Capital Partners and the company’s founder-shareholders. The deal strengthens CenterWell’s presence in Florida, adding a network of 54 owned primary care clinics, four specialty centers, and 24 affiliate clinics across West and South Florida. MaxHealth serves over 120,000 patients, including more than 80,000 in value-based care programs. The acquisition aligns with CenterWell’s strategy to expand its integrated, patient-centered care delivery network and enhance access to high-quality, coordinated healthcare services for seniors and other patients across the region. (Link)
  10. CSD Acquires New Mexico’s Leading Autism Provider BCI in Strategic Merger to Boost Southwest Access, Innovation, and Evidence-Based Behavioral Care Nationwide via its financial sponsors NMS Capital, CD Private Equity, and Goldman Sachs Asset Management Center for Social Dynamics (CSD), a top national autism therapy provider, has acquired Behavior Change Institute (BCI), New Mexico’s premier autism care organization known for clinical expertise and equitable access. Announced February 19, 2026, the deal unites research-driven models, shortening wait times and blending in-person, virtual, and tech-enhanced therapies. CSD CEO Kelly Bozarth hailed it as a “values-driven union” for faster breakthrough care. BCI leaders emphasized scaling their mission nationally while preserving clinical culture. Families retain teams with added CSD tools; the merger advances research, clinician training, and outcomes in underserved areas. (Link)
  11. VB Spine LLC Acquires Exclusive Rights to Augmedics’ FDA-Cleared xvision Spine System®, Bolstering AR Navigation Leadership in Spine Surgery with Nearly 13,000 Cases of Proven Use VB Spine LLC, the largest privately held spine company, announced a definitive agreement to acquire exclusive rights to Augmedics’ groundbreaking xvision Spine System®, the first FDA-cleared AR navigation platform for spine surgery. This move enhances VB Spine’s visualization portfolio, following its recent SpineHawk™ acquisition, and positions it as a global leader in AR-enabled solutions. xvision offers direct-patient visualization, precision, workflow efficiency, and radiation reduction, with nearly 13,000 procedures completed. The deal, expected to close soon pending approvals, supports VB Spine’s strategy to redefine spine care. (Link)
  12. St. David’s HealthCare Acquires Cardiothoracic and Vascular Surgeons, Strengthening Central Texas Cardiovascular Expertise in Strategic Integration Austin-based St. David’s HealthCare, part of HCA Healthcare and local nonprofits, has acquired Cardiothoracic and Vascular Surgeons (CTVS) on Feb. 15. The system, with nine hospitals, 190 care sites, and over 12,600 employees, will keep CTVS’s name, operations, physicians, providers, and 45 staff intact while aligning them under St. David’s. “This integration builds on decades of collaboration to elevate care and innovation,” said CEO David Huffstutler. The move advances cardiovascular standards in Central Texas. (Link)
  13. Epiphany Dermatology Expands Missouri Footprint with Strategic Partnership Joining Regional Dermatology’s St. Louis Clinics in Chesterfield and Festus Epiphany Dermatology has partnered with Regional Dermatology, LLC, founded in 2010 by board-certified dermatologist Sarah Jensen, M.D., to boost its presence in Missouri’s St. Louis market. The deal integrates Jensen’s team—including two advanced practice providers—at two locations: Chesterfield (West) and Festus. This enhances access to high-quality dermatology services like general care, skin cancer treatment, and Mohs surgery. Jensen praised Epiphany’s patient-focused values, while CEO Gheorghe Pusta highlighted the cultural fit and shared expertise. Epiphany now supports operations, marketing, and recruiting, operating 121 locations across 18 states from Austin, Texas. (Link)
  14. Gilead to Acquire Arcellx for Up to $7.8 Billion, Expanding Oncology and Cell Therapy Pipeline Gilead Sciences has agreed to acquire Arcellx in a transaction valued at up to $7.8 billion, strengthening its position in next-generation cell therapies for cancer. Arcellx’s lead programs focus on innovative immunotherapy approaches designed to improve durability and safety in hematologic malignancies. The acquisition builds on Gilead’s broader oncology strategy and deepens its commitment to high-growth, high-innovation therapeutic areas. The deal underscores continued large-cap biopharma appetite for differentiated oncology assets amid competitive cell therapy development. (Link)
  15. Viventium Acquires Apploi to Launch Unified HCM Platform Revolutionizing Post-Acute Care Workforce Management Amid Labor Crisis via its financial sponsor LLR Partners Viventium has acquired Apploi, creating a category-leading human capital management (HCM) platform tailored for post-acute and long-term care providers. The unified system integrates recruiting, credentialing, onboarding, payroll, scheduling, and compliance across all 50 states, addressing labor shortages and fragmented software silos. Viventium CEO Navin Gupta highlighted ending “fractured systems,” while Apploi CEO Adam Lewis emphasized full employee lifecycle support. Serving thousands of providers and hundreds of thousands of employees, the deal closed January 30, 2026. Financial terms undisclosed. (Link)
  16. Invo Fertility (Nasdaq: IVF), Acquires Indianapolis’ Family Beginnings for $760K, Bolstering Midwest Presence and Projecting $9M Clinic Revenue in 2025 Amid Growth Pivot Invo Fertility Inc. (Nasdaq: IVF), based in Sarasota, has acquired the nonclinical assets of Midwest fertility clinic Family Beginnings in Indianapolis for $760,000 in cash and preferred stock. The deal preserves Dr. James Donahue’s leadership and the existing team, with Invo providing operational support and tech investments. Family Beginnings reported $1M revenue and $200K net income for the nine months ended Sept. 30, 2025—18% of Invo’s clinic revenue. Now with four clinics, Invo eyes $9M combined 2025 revenue, up from 2024’s $6.5M total (with $9.1M net loss). CEO Steve Shum calls it an “inflection point,” targeting acquisitions, organic growth, and 2026 expansion via marketing and tech. (Link)
  17. Northwell Health Bolsters South Shore Presence with $9.5M Off-Market Acquisition of Merrick Orthopedic Office Building from Berkeley Capital Northwell Health has expanded its real estate holdings by acquiring a 17,714-square-foot medical office building at 1728-1732 Sunrise Highway in Merrick for $9.5 million in an off-market deal. The property, on 0.46 acres, houses Northwell affiliate Orlin & Cohen Orthopedic Group, with about three years remaining on its lease. Northwell, self-represented, bought from Berkeley Capital LLC, represented by North Village Realty’s Tom Bigansky. The move secures long-term healthcare delivery in South Shore communities, reflecting generational planning and market confidence, Bigansky noted. (Link)
  18. Sensei Biotherapeutics (Nasdaq: SNSE) Acquires Faeth Therapeutics in $200M-Backed Deal to Advance PIKTOR Cancer Therapy Sensei Biotherapeutics (Nasdaq: SNSE) has acquired Faeth Therapeutics, gaining its lead asset PIKTOR—an investigational all-oral combo of serabelisib and sapanisertib targeting the PI3K/AKT/mTOR pathway for endometrial and breast cancers. Concurrently, Sensei secured $200 million in Series B preferred stock financing from top investors like RA Capital, Vivo Capital, and Cormorant. Proceeds will fund Phase 2 topline data in endometrial cancer and a Phase 1b breast cancer trial by end-2026, plus ongoing solnerstotug studies. Post-deal, Faeth holders own 40.8%, investors 54.3%, and prior Sensei shareholders 4.9% on a fully diluted basis. (Link)
  19. Kinderhook Industries to Take Home Health and Hospice Provider Enhabit (NYSE: EHAB) Private in $1.1B Deal Private equity firm Kinderhook Industries has agreed to acquire Enhabit Inc., a Dallas-based home health and hospice services provider, in a transaction valued at approximately $1.1 billion. Under the terms of the deal, Enhabit shareholders will receive $13.80 per share in cash, representing a premium to the company’s recent trading levels. The transaction is expected to close in Q2 2026, at which point Enhabit’s shares will be delisted from the NYSE. The acquisition reflects continued PE interest in the home health and hospice sector amid demographic tailwinds and demand for at-home care services. (Link)

Venture and Other News:

  1. Rainfall Health Secures $15M Series A to Supercharge AI Compliance Platform Amid CMS’s TEAM Mandate Launch, Unlocking $100M+ Revenue for Hospitals Rainfall Health, an AI-driven compliance platform for hospitals, closed a $15 million Series A round led by Two Bear Capital. The funding will expand AI and customer support teams to aid providers under CMS’s new Transforming Episode Accountability Model (TEAM), launched January 1, 2026. TEAM targets high-cost surgeries like joint replacements and spinal fusions, offering 20% revenue boosts—over $100 million per health system—for meeting quality metrics. CEO Eddie Qureshi emphasized high-quality post-acute care. Backed by experts like former VA Secretary David Shulkin, Rainfall sets a national standard for value-based reimbursement and patient outcomes. (Link)
  2. ProSomnus Secures $38 Million Strategic Investment from Catalio Capital to Advance Next‑Generation Smart Sleep Medicine Platform ProSomnus Sleep Technologies, a leader in non‑CPAP Obstructive Sleep Apnea (OSA) therapy, announced a $38 million strategic investment from healthcare investor Catalio Capital Management to accelerate global expansion and technology development. The funding will support next‑generation remote patient monitoring, proprietary sleep diagnostic devices, and comparative clinical studies. CEO Len Liptak emphasized that the partnership validates ProSomnus’s mission to deliver data‑driven, patient‑preferred OSA therapies. CFO Jason Orchard noted the investment will optimize infrastructure and enhance patient outcomes. Catalio’s Dr. Nicholas von Guionneau joins as Board Observer, highlighting ProSomnus’s leadership in connected, precision sleep solutions. (Link)
  3. Dallas-Based SpendRule Exits Stealth with $2M Seed Round from Abundant Venture Partners, MemorialCare Innovation Fund, and Zeal Capital Partners to Automate AI-Powered Contract Compliance and Invoice Validation for Hospitals like OSF HealthCare, Kettering Health, MemorialCare, and MUSC Health SpendRule, founded by Chris Heckler and Joseph Akintolayo, automates contract compliance and invoice validation for health systems. Its AI software checks purchased services invoices against contract terms pre-payment, integrating seamlessly with ERP systems, contract management, and accounts payable workflows. The funding will expand the team and advance AI infrastructure. Backed by Abundant Venture Partners—a Chicago VC focused on healthcare innovation with a network of 22+ provider organizations—SpendRule serves major clients including OSF HealthCare, Kettering Health, MemorialCare, and MUSC Health. (Link)
  4. Covetrus and MWI Animal Health Strike $3.5 Billion Merger Deal, Forming Tech-Enhanced Platform with Cencora Retaining Major Stake Covetrus and MWI Animal Health announced a blockbuster $3.5 billion merger on February 18, creating a unified “comprehensive animal health platform.” MWI’s owners, Cencora, will receive $1.25 billion in cash and equity stakes, retaining a 34.3% share in the new entity. Leaders hailed the deal for blending MWI’s supply chain prowess and customer ties in companion and production animal sectors with Covetrus’ tech-driven veterinary solutions. The combo promises enhanced logistics, cost savings, broader customer reach—from vets and producers to pet owners—and accelerated innovation to make animal care more affordable and accessible. (Link)
  5. Grail’s Galleri Multi-Cancer Early Detection Blood Test Misses Primary Endpoints in Large Screening Trial Grail’s Galleri multi-cancer early detection blood test recently failed to meet its primary endpoints in a large clinical screening study, raising doubts about its effectiveness as a broad population screening tool. Following the release of these results, the company’s stock experienced a significant decline as investors reassessed commercial prospects. The data suggested lower than expected sensitivity for detecting certain cancers, which could complicate regulatory and reimbursement pathways. The outcome underscores ongoing challenges for next-generation liquid biopsy tests in proving clinical utility at scale. (Link)